06 / May / 2026 “Science is a state program, not a government project,” says scientist among the 107 most influential Brazilians in the world From vaccines to major epidemics, Maurício Nogueira has taken discoveries from the laboratory to public policy and is among the 107 most influential Brazilian scientists in the world By Yasmim Cunha
27 / April / 2026 Science in Latin America is growing, but underinvestment continues, says Gabriela Dutrénit A leading figure in innovation policy, Mexican researcher analyzes structural constraints and pathways for increasing the region’s scientific prominence By Moura Leite Netto
22 / April / 2026 Harald Gaski: “Indigenous peoples can also have journals of excellence” Former editor of the only scientific journal written entirely in an Indigenous language and indexed in DOAJ discusses language preservation, academic decolonization, and the limits of international recognition By Samuel Fernandes
15 / April / 2026 Hugo Aguilaniu: “Without scientific philanthropy, Brazil is giving up on risk.” Serrapilheira Institute director assesses Brazil’s research funding system and links risk aversion to the absence of a Brazilian Nobel laureate By Daniel Dieb
13 / April / 2026 “Without data, renewal in science becomes just rhetoric” A researcher at the Federal University of ABC mapped the academic age of faculty members across the country and identified limited renewal at the foundation of graduate programs. By Yasmim Cunha
08 / April / 2026 “Without suitable comparison between groups, there is no way of proving the efficacy of a new drug” Cardiologist and researcher at Einstein Hospital Israelita explains the role of randomized clinical trials and the risks of social pressure on clinical research By Moura Leite Netto
13 / March / 2026 How monoclonal antibodies are redefining the fight against HIV Research led by Marina Caskey reveals the potential of monoclonal antibodies capable of neutralizing multiple strains of HIV and keeping the virus under control for long periods By Samuel Fernandes
05 / March / 2026 “Without a control group, we cannot say that polylaminin works,” says coauthor of study on the substance For neurosurgeon and UFRJ professor Paulo Louzada, flaws in the methodology prevent conclusions about the effectiveness of polylaminin By Moura Leite Netto
04 / March / 2026 Only 12 Brazilian universities regulate the use of AI USP survey finds that artificial intelligence governance is progressing slowly in higher education; expert calls for a pedagogical, nonpunitive approach By Samuel Fernandes
25 / February / 2026 Physician-scientist career still faces barriers in Brazil Fiocruz physician discusses the challenges of a dual career, the lack of sustained funding, and the strategic role of research in the Brazilian public health system (SUS) By Yasmim Cunha
